Hesperion expands in Eastern Europe

Hesperion, a contract research organisation (CRO) and a subsidiary of Cerep, has opened a new office in Moscow. The company considers this a major step in its Eastern Europe expansion and a factor that will increase its attractiveness in the eyes of clinical trial sponsors wishing to conduct global research.

Hesperion’s Russian office is to provide a full range of standard CRO services, in addition to specialised facilities necessary due to the specific legal and regulatory requirements in Russia. One extra service offered is registration of new medications on the Russian market.
Aspects that should appeal to potential sponsors are Hesperion Russia’s database of research sites, covering the European part of Russia as well as Siberia and the Far East, and its staff – local CRAs, doctors specialising in cardiology, oncology, endocrinology, gastroenterology, paediatrics, gynaecology and psychiatry.

According to Dr. Markus Weissbach, CEO of Hesperion, the Russian office will also be a convenient location for managing studies in Ukraine, Belarus, Kazakhstan and other neighbouring countries.

Source: PMR. For more info Pharmapoland.com